v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Commercialization revenue $ 27,357 $ 884
License and collaboration revenue 0 342
Total revenue 27,357 1,226
Costs and operating expenses:    
Cost of commercialization revenue 1,985 216
Research and development expenses 45,506 62,156
General and administrative expenses 11,113 13,872
Total costs and operating expenses 58,604 76,244
Loss from operations (31,247) (75,018)
Other income (expense), net:    
Interest income 604 1,802
Interest expense (1,153) (1,336)
Other income (expense), net 68 (197)
Total other income (expense), net (481) 269
Loss before provision for (benefit from) income taxes (31,728) (74,749)
Provision for (benefit from) income taxes 24 22
Net loss (31,752) (74,771)
Other comprehensive gain (loss):    
Unrealized gain (loss) on available-for-sale securities 149 830
Comprehensive loss $ (31,603) $ (73,941)
Basic loss per common share $ (0.23) $ (0.72)
Diluted loss per common share $ (0.23) $ (0.72)
Basic weighted-average shares outstanding 140,587 103,969
Diluted weighted-average shares outstanding 140,587 103,969

Source